Lensar (LNSR) EPS (Diluted) Growth (3y) (2024 - 2026)
Lensar (LNSR) EPS (Diluted) Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 18.07% |
| 10 | Lensar | 101.76 Mn | 88.19 Mn | 9.78 Mn | 28.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.12% |
| Mar 31, 2026 | 71.87% |
| Dec 31, 2025 | 20.77% |
| Sep 30, 2025 | 7.56% |
| Jun 30, 2025 | 39.61% |
| Mar 31, 2025 | -51.37% |
| Dec 31, 2024 | -57.42% |
| Sep 30, 2024 | 41.67% |
| Jun 30, 2024 | -18.95% |